These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25440805)

  • 1. Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials.
    Bagai A; Tan M; Di Mario C; Halvorsen S; Cantor WJ; Le May MR; Fernandez-Aviles F; Scheller B; Armstrong PW; Borgia F; Piscione F; Sánchez PL; Westerhout CM; Goodman SG; Yan AT
    Am Heart J; 2014 Nov; 168(5):757-65. PubMed ID: 25440805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a routine early invasive strategy in relation to time from symptom onset to fibrinolysis (a subgroup analysis of TRANSFER-AMI).
    Russo JJ; Goodman SG; Cantor WJ; Tan MK; Borgundvaag B; Fitchett D; Džavík V; Yan RT; Graham JJ; Mehta SR; Yan AT;
    Am J Cardiol; 2015 Apr; 115(8):1005-12. PubMed ID: 25711435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.
    Russo JJ; Goodman SG; Cantor WJ; Fitchett D; Heffernan M; Borgundvaag B; Ducas J; Cohen EA; Džavik V; Mehta SR; Buller CE; Yan AT;
    Heart; 2014 Jun; 100(11):873-80. PubMed ID: 24449716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis.
    Abdel-Qadir H; Yan AT; Tan M; Borgia F; Piscione F; Di Mario C; Halvorsen S; Cantor WJ; Westerhout CM; Scheller B; Le May MR; Fernandez-Aviles F; Sánchez PL; Lee DS; Goodman SG
    Heart; 2015 Oct; 101(19):1554-61. PubMed ID: 26175478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Bhan V; Cantor WJ; Yan RT; Mehta SR; Morrison LJ; Heffernan M; Fitchett D; Džavík V; Ducas J; Borgundvaag B; Cohen EA; Goodman SG; Yan AT
    Am Heart J; 2012 Sep; 164(3):343-50. PubMed ID: 22980300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials.
    Madan M; Halvorsen S; Di Mario C; Tan M; Westerhout CM; Cantor WJ; Le May MR; Borgia F; Piscione F; Scheller B; Armstrong PW; Fernandez-Aviles F; Sanchez PL; Graham JJ; Yan AT; Goodman SG
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):166-174. PubMed ID: 25616922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Cantor WJ; Fitchett D; Borgundvaag B; Heffernan M; Cohen EA; Morrison LJ; Ducas J; Langer A; Mehta S; Lazzam C; Schwartz B; Dzavik V; Goodman SG
    Am Heart J; 2008 Jan; 155(1):19-25. PubMed ID: 18082484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.
    Elbarouni B; Cantor WJ; Ducas J; Borgundvaag B; Džavík V; Heffernan M; Buller CE; Langer A; Goodman SG; Yan AT;
    Can J Cardiol; 2014 Dec; 30(12):1555-61. PubMed ID: 25475460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Yan AT; Yan RT; Cantor WJ; Borgundvaag B; Cohen EA; Fitchett DH; Dzavik V; Ducas J; Tan M; Casanova A; Goodman SG;
    Eur Heart J; 2011 Aug; 32(16):1994-2002. PubMed ID: 21307037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine early angioplasty after fibrinolysis for acute myocardial infarction.
    Cantor WJ; Fitchett D; Borgundvaag B; Ducas J; Heffernan M; Cohen EA; Morrison LJ; Langer A; Dzavik V; Mehta SR; Lazzam C; Schwartz B; Casanova A; Goodman SG;
    N Engl J Med; 2009 Jun; 360(26):2705-18. PubMed ID: 19553646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smokers with ST-segment elevation myocardial infarction and short time to treatment have equal effects of PCI and fibrinolysis.
    Rasmussen T; Kelbæk H; Madsen JK; Thayssen P; Rasmussen K; Thuesen L; Køber L
    J Invasive Cardiol; 2012 Aug; 24(8):401-6. PubMed ID: 22865311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
    Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; Dimopoulos K; Scheller B; Armstrong PW; Di Mario C
    Eur Heart J; 2010 Sep; 31(17):2156-69. PubMed ID: 20601393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA; Clayton TC; Damman P; Pocock SJ; de Winter RJ; Tijssen JG; Lagerqvist B; Wallentin L;
    J Am Coll Cardiol; 2010 Jun; 55(22):2435-45. PubMed ID: 20359842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.
    Graham JJ; Yan AT; Tan MK; Cantor WJ; DiMario C; Jolly SS; Halvorsen S; Fernandez-Aviles F; Le May MR; Scheller B; Borgia F; Piscione F; Madan M; Goodman SG
    Cardiovasc Revasc Med; 2016; 17(5):295-301. PubMed ID: 27116940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Balan P; Cai C; Sdringola S; Denktas AE; Smalling RW; Anderson HV
    Am J Cardiol; 2014 Jan; 113(1):60-3. PubMed ID: 24207074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.